Clinical Trial Update: Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining the pathophysiology and treatment of demyelination in multiple sclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Elliot Frohman | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED